Ivabradine in the Acute Management of Cardiogenic Shock
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT07714746
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 200 participants
- Registry
-
NCT07714746
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Pakistan
- Registry status
- Recruiting
Technical summary
Registry record NCT07714746. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-20 (actual); primary completion 2027-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ivabradine in the Acute Management of Cardiogenic Shock
- Acronym
- IVASHOCK
- Condition
- Cardiogenic Shock Post Myocardial Infarction
- Intervention (Drug)
- Ivabradine 5mg Tab
- Intervention (Drug)
- Placebo Oral Tablet
- Lead sponsor
- National Institute of Cardiovascular Diseases, Pakistan
Record details
- Record id
cardio:ct-nct07714746- Content hash
4a3aa95bfa5cf0f982f8852b4fe3f54acf157092ef13a34a0d53a3a2302755ce